2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of cardiology foundation/American heart association task force on practice guidelines

Bernard J. Gersh, Barry J. Maron, Robert O. Bonow, Joseph A. Dearani, Michael A. Fifer, Mark S. Link, Srihari S. Naidu, Rick A. Nishimura, Steve R. Ommen, Harry Rakowski, Christine E. Seidman, Jeffrey A. Towbin, James E. Udelson, Clyde W. Yancy

Research output: Contribution to journalReview article

487 Scopus citations
Original languageEnglish (US)
Pages (from-to)2761-2796
Number of pages36
JournalCirculation
Volume124
Issue number24
DOIs
StatePublished - Dec 13 2011

Keywords

  • AHA Scientific Statements
  • ablation
  • cardiomyopathy, hypertrophic
  • defibrillators, implantable
  • hypertrophy
  • myocardial disease
  • surgical procedures, operative

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., Seidman, C. E., Towbin, J. A., Udelson, J. E., & Yancy, C. W. (2011). 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of cardiology foundation/American heart association task force on practice guidelines. Circulation, 124(24), 2761-2796. https://doi.org/10.1161/CIR.0b013e318223e230